MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
8.31
+0.16
+1.96%
After Hours: 8.31 0 -0.02% 19:29 12/31 EST
OPEN
8.13
PREV CLOSE
8.15
HIGH
8.31
LOW
8.08
VOLUME
1.06M
TURNOVER
--
52 WEEK HIGH
17.58
52 WEEK LOW
5.00
MARKET CAP
503.50M
P/E (TTM)
-1.3350
1D
5D
1M
3M
1Y
5Y
1D
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
NASDAQ · 12/31/2025 23:15
Weekly Report: what happened at DNA last week (1222-1226)?
Weekly Report · 12/29/2025 09:32
Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0%
Simply Wall St · 12/26/2025 10:07
Ginkgo Bioworks realigns leadership, shifts COO responsibilities
TipRanks · 12/23/2025 22:50
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans
Benzinga · 12/22/2025 20:47
Ginkgo Bioworks partnres with CMU to develop cancer screening approach
TipRanks · 12/22/2025 18:25
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
PR Newswire · 12/22/2025 18:21
Weekly Report: what happened at DNA last week (1215-1219)?
Weekly Report · 12/22/2025 09:32
More
About DNA
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The Company provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including NYSE: DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.